US 11672774
Methods of treating squamous cell carcinomas with farnesyltransferase inhibitors
granted A61KA61K2239/31A61K2239/38
Quick answer
US patent 11672774 (Methods of treating squamous cell carcinomas with farnesyltransferase inhibitors) held by Kura Oncology, Inc. expires Mon Jun 08 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Kura Oncology, Inc.
- Grant date
- Tue Jun 13 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 08 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 50
- CPC classes
- A61K, A61K2239/31, A61K2239/38, A61K31/045, A61K31/223